![[horizontal rule]](ehshr.gif)
| Effective: 7/8/2003 |
Revised: 7/1/2007 |
![[ASU logo]](asu.gif) |
EHS 112: Biosafety and the
Possession, Use, and Transfer of Select Agents and
Toxins |
![[horizontal rule]](ehshr.gif)
Purpose
![[horizontal rule]](ehshr.gif)
To ensure that biohazard and recombinant DNA activities at ASU
are conducted safely and in accordance with applicable statutes,
rules, regulations, standards, and university policy
![[horizontal rule]](ehshr.gif)
Background
![[horizontal rule]](ehshr.gif)
ASU has instituted and maintains a biosafety program for the
possession, use, transfer and storage of biohazards and recombinant
DNA and for laboratory employees who may be exposed to biohazards
during the performance of their duties. The biosafety program is
designed to promote and achieve regulatory compliance and provides
a means for laboratory employees to be better informed about and
protected from biohazards.
![[horizontal rule]](ehshr.gif)
Sources
![[horizontal rule]](ehshr.gif)
7 Code of Federal Regulations §
331
9 Code of Federal Regulations §
121
42 Code of Federal Regulations §§ 73,
1003
US Patriot Act, 18 United States Code
§ 175b
Bioterrorism Preparedness and Response Act of
2002, HR3448, Public Act 107-188
Centers for Disease Control & Prevention/National
Institutes of Health. Biosafety in Microbiological and
Biomedical Laboratories. 4th Ed. May, 1999
Department of Health and Human Services. National
Institutes of Health. Guidelines for Research Involving
Recombinant DNA Molecules. May 7, 1986
Arizona State University Biosafety
Manual
![[horizontal rule]](ehshr.gif)
Applicability
![[horizontal rule]](ehshr.gif)
ASU academic, research, and other operations involved in the
possession, use, transfer, or storage of biohazards and/or
recombinant DNA. This applies to activities involving:
- CDC/USDA select agents and toxins
- recombinant DNA, including experiments that are specifically
exempt under the NIH Guidelines
- bacterial, fungal, parasitic, or other potentially infectious
agents
- live viruses
- biohazard exposure to research animals
- human blood and tissue
and
- infectious waste.
The list of select agents and toxins in the select agent
regulations is available at
http://www.cdc.gov/od/sap/docs/salist.pdf.
![[horizontal rule]](ehshr.gif)
Policy
![[horizontal rule]](ehshr.gif)
Responsibilities of the Department of
Environmental Health & Safety
Biosafety Officer
The university Biosafety Officer (BSO) is responsible for the
following:
- develops and maintains the university’s biosafety
program, including select agents and toxins
- reviews and approves registration for research proposals
involving biohazards and recombinant DNA in coordination with the
Institutional Biosafety Committee (IBC) and Office for Research and
Sponsored Projects Administration (ORSPA)
- consults with researchers on issues of biosafety and the safe
use of biohazards in the laboratory
- develops protocols and procedures for biosafety
- advises researchers on proper waste disposal methods
- provides oversight of the Arizona State University Exposure
Control Plan for Bloodborne Pathogens; Needlesticks and Other
Sharps Injuries
- conducts required initial and annual training for laboratory
personnel with potential biohazard exposures in their
workplace
- conducts annual laboratory biosafety audits to determine
compliance status
and
- promotes regulatory compliance and a safe laboratory work
environment.
The BSO is the director of Environmental Health & Safety or
designee and serves as the university’s Alternate Responsible
Official (ARO) for the select agents and toxins program.
Responsibilities of Departments and
Units
Departments and units must identify laboratory employees who use
and/or may be exposed to biohazards and ensure that these employees
are provided the protections required when working with
biohazards.
Deans, Directors, and Chairs
Deans, directors, and chairs of colleges, departments, and other
units have the primary responsibility for the biosafety of people,
animals, and the environment within their jurisdiction. They
receive from the IBC the material for registration of biological
research; ensure that registration forms are completed by each
principal investigator conducting applicable research; and submit
completed registration forms to the IBC.
Principal Investigators
Principal Investigators (PI) in charge of biohazard or
recombinant DNA activities are responsible for ensuring the health
and safety of those working with those materials. The PI completes
and submits registration forms for all research proposals involving
the use of biohazards, including select agents and toxins and
recombinant DNA, and develops specific biosafety standard operating
procedures for each biohazard and select agent and toxin used in
the laboratory.
The PI must ensure the following:
- that proper training and instruction are provided for
laboratory personnel in safe practices and protocols, including, at
a minimum, training in aseptic techniques and biology of the
organism(s) being used
- that laboratory personnel receive any necessary medical
surveillance
- that biosafety cabinets are certified as needed
- that personal protective equipment is provided and used
and
- that laboratory personnel are in compliance with applicable
statutes, rules, regulations, standards, and university
policy.
Responsibilities of Employees
Laboratory employees who use biohazards or recombinant DNA
during the performance of their duties have the following
responsibilities:
- participate in appropriate training and instruction
- become familiar with biohazards, select agents and toxins, and
recombinant DNA being used in the laboratory and the potential
risks associated with exposure
- follow all laboratory practices and protocols and comply with
all applicable statutes, rules, regulations, standards, and
university policy
- participate in medical surveillance as required
and
- report all thefts, security incidents, accidents, spills, or
contamination incidents to the laboratory supervisor.
Institutional Biosafety Committee
The Institutional Biosafety Committee (IBC) analyzes university
operations and facilities involving, or proposed to be involved in,
biohazard and recombinant DNA activities. The IBC is appointed by
and responsible to the vice president for Research and Economic
Affairs and recommends actions necessary to maintain and/or improve
biosafety.
Tasks of the IBC include the following:
- initiate the registration of biohazard and recombinant DNA
research by providing department chairs with the registration
materials
- review and approve research proposals involving recombinant DNA
and biohazards and approve those that comply with NIH and CDC
guidelines and university policy
- review and approve research proposals involving the use of
select agents and toxins
- adopt policies supporting the safe use of biohazards and the
elimination or reduction of exposure to biohazards
and
- address biosafety issues related to experimentally infected
laboratory animals.
![[horizontal rule]](ehshr.gif)
ProceduresD
![[horizontal rule]](ehshr.gif)
Research Involving Recombinant DNA, Infectious
Agents (other than Select Agents and Toxins) or Other Biosafety
Matters
Responsibility
|
Action
|
| Principal investigator or researcher |
- Contact the chair of the Institutional Biosafety Committee
(IBC) to initiate a review of the project.
| Note: |
Each researcher is primarily responsible for ensuring safety in
activities involving recombinant DNA or gene-splicing techniques,
infectious microorganisms, infectious waste, or hazardous and toxic
chemicals |
- Become familiar with the Arizona State University Biosafety
Manual and, if applicable, complete the Recombinant DNA and Artificial Gene Transfer
Form or the Infectious Agent Use
Form. Submit the form(s) to the IBC coordinator.
| Note: |
General questions and information regarding the Arizona
State University Biosafety Manual can be obtained by calling
Environmental Health & Safety at 480/965–1823 or by
contacting them at risk@asu.edu. | |
| Institutional Biosafety Committee |
- Distribute the Arizona State University Biosafety Manual
and registration forms to anyone requesting them and those who may
work with recombinant DNA, infectious agents, or other biosafety
concerns.
| Note: |
The IBC advises the vice president for Research and Economic
Affairs regarding these activities and certifies compliance with
the National Institutes of Health guidelines for all projects
involving recombinant DNA molecules and/or gene-splicing
techniques. |
- Review the completed form(s) to determine whether the project
meets federal and university standards.
- Approve or disapprove the project.
If the project is not approved:
- Return the form(s) unsigned to the principal investigator or
researcher, with comments for discussion.
If the project is approved:
- Sign the form(s) and forward it to the Biosafety Officer (BSO),
Institutional Animal Care and Use Committee (IACUC) (if necessary),
and the Office for Research and Sponsored Projects Administration
(ORSPA).
|
| Institutional Animal Care and Use Committee (IACUC) |
- Review the completed form if the use of animals is
involved.
- Approve or disapprove the project.
If the project is not approved:
- Return the form(s) unsigned to the principal investigator or
researcher, with comments for discussion and resolution.
If the project is approved:
- Sign the form(s) and forward it to the BSO and
ORSPA.
|
| Office for Research and Sponsored Projects Administration |
- Review the form(s) to determine whether the project meets
federal and university standards.
- Approve or disapprove the project.
If the project is not approved:
- Return the form(s) unsigned to the principal investigator or
researcher, with comments for discussion and resolution.
If the project is approved:
- Sign the form(s) and forward it to the IBC
coordinator.
|
| Biosafety Officer |
- Review the form(s) to determine whether the project meets
federal and university standards.
- Approve or disapprove the project.
If the project is not approved:
- Return the form(s) unsigned to the principal investigator or
researcher, with comments for discussion and resolution.
If the project is approved:
- Sign the form(s) and forward it to the IBC
coordinator.
|
| IBC Chair |
- Send a copy of the approved form(s) to the principal
investigator or researcher and retain the original for
administrative records.
| Note: |
These forms must be completed
annually. | |
Research Involving Select Agents and
Toxins
In addition to the above described procedures, select agents are
subject to the additional following requirements:
Responsibility
|
Action
|
| Executive vice president for Administration and Finance and the
vice president for Research and Economic Affairs |
- Appoint the university’s select agent Responsible
Official (RO) and Alternate Responsible Official (ARO) in
accordance with select agent regulations.
|
| RO |
- Establish policies, procedures, protocols, and forms involving
the possession, use, and transfer of select agents at ASU
facilities in accordance with the Centers for Disease Control and
Prevention (CDC) and the United States Department of Agriculture
(USDA) select agent regulations and other applicable local, state,
and federal statutes, rules, regulations, standards, and university
policy.
| Note: |
Such policies, procedures, protocols, and forms shall provide
for registration, security clearance, restrictions on access,
safety, emergency plans, biocontainment, security plans, and such
other measures deemed necessary or prudent to carry out the
requirements for select
agents. |
|
| Principal investigator (PI) |
- Complete the Select Agent and
Toxin Pre-Registration Form and submit to the RO for
permission.
| Note: |
ASU must register select agents and toxins with CDC and/or
USDA. Each agent must be registered individually if any PI working
in an ASU facility possesses, uses, or transfers select agents. No
such individuals shall possess, use, or transfer select agents
without prior written approval of the ASU Institutional Biosafety
Committee (IBC). |
|
| BSO |
- Obtain security clearance from the Department of Justice for
individuals with access to select agents.
| Note: |
Individuals with access to select agents who do not have
security clearance must be accompanied and monitored at all times
by a person who has received a security clearance.
The USA Patriot Act (paragraph 175b) prohibits
“Restricted Persons” from working with select agents.
Persons restricted from working with select agents can be found on
the following website:
http://www.epic.org/privacy/terrorism/hr3162.html. |
|
| RO |
- Inspect annually laboratories and campus facilities possessing,
using, transferring, or receiving select agents to ensure that all
requirements are being met.
| Note: |
If a facility is found to be non-compliant the select agent
registration with CDC may be revoked. Practices and procedures for
safe use of select agents will be based on the conditions set forth
in CDC-NIH “Biosafety in Microbiological and Biomedical
Laboratories.”
The ASU Specific Biosafety Emergency response plan is contained
in the Biosafety Manual. General questions and information
regarding the Arizona State University Biosafety Manual can
be obtained by calling Environmental Health & Safety at
480/965–1823 or by contacting them at risk@asu.edu. |
|
| PI and BSO |
- Conduct training for all personnel possessing, using,
transferring, or receiving select agents regarding:
- the symptoms of exposure
- a post-exposure management protocol
- spill cleanup and decontamination
- proper use of engineering, administrative, and work practice
controls
and
- personal protective equipment, and security requirements for
select agent possession and use.
|
| PI |
- Notify the RO when a select agent is destroyed or
depleted.
|
| RO |
- Notify the CDC of intent to destroy the select agent at least
five working days prior to the planned destruction (CDC Form
1318).
|
|
- Maintain a record of the destruction for three
years.
|
|
- If the PI no longer has select agents, notify the CDC to have
the PI removed from the registration.
|
|
- Consult with the ASU Police Department in carrying
out a safety and emergency response plan related to the possession,
use, and transfer of select agents.
| Note: |
All laboratories and campus facilities possessing, using,
transferring, or receiving select agents must comply with all of
the security requirements established by the Centers for Disease
Control and Prevention for the inventory and containment of select
agents. CDC minimum recommendations are listed in the Biosafety in
Microbiological and Biomedical Laboratories (BMBL) Appendix F,
http://www.cdc.gov/od/ohs/biosfty/bmbl4/b4af.htm.
The ASU Specific Biosafety Emergency response plan is contained
in the Arizona State University Biosafety Manual. General
questions and information regarding the Arizona State University
Biosafety Manual can be obtained by calling Environmental
Health & Safety at 480/965–1823 or by contacting them at
risk@asu.edu. | |
Compliance
- The RO is responsible for enforcing this policy.
- The RO shall consult with the IBC, the Biosafety Officer, the
Police Department, ASU General Counsel, Information
Technology, and others in responding to technical issues and
implementation of this policy.
- A person aggrieved by a decision of ORSPA or BSO may appeal
that decision to the executive vice president for Administration
and Finance within 10 working days of ORSPA’s or BSO’s
decision. The decision of the executive vice president shall be
final.
endtable
![[horizontal rule]](ehshr.gif)
Cross-References
![[horizontal rule]](ehshr.gif)
For more information, see:
- EHS 101, “Bloodborne Pathogens
and Needlestick Prevention”
- EHS 103, “Hazard Communication
Program”
- EHS 105, “Personal Protective
Equipment”
- EHS 108, “Environmental Health
and Safety Training”
- EHS 205, “Storage of Hazardous
Chemicals”
and
- EHS 403, “Chemical Release
Emergency Response.”
See also the Police Department Policies and
Procedures Manual— PDP
104–01, “Laboratory Emergencies.”
skip navigation bar
EHS manual |
ASU policies and procedures manuals | Index of Policies by Title | EHS manual contact | Environmental Health & Safety Web site
Back to
Top
